Investitionsthese
Kurma Partners transforms disruptive scientific discoveries from leading European academic research into cutting-edge medicines and medical devices, partnering with research teams and entrepreneurs to build high-tech healthcare companies.
Investitionsphase
Seed to Series A (early-stage companies and companies founded from research discoveries)
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Early-stage and seed funding for disruptive scientific discoveries in healthcare and biotechnology, focusing on high-tech companies and medical devices for severe diseases with unmet medical needs.
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
€7.000.000 - €84.000.000
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
Investment Team (28)
A
Alain Horvais
Partner
A
Amanda Gett
Partner
A
Anna Tchorzewska
Associate
B
Benjamin Belot
Partner
B
Benjamin Belot 2b5b61b
Partner
C
Cyril Bedran
Directeur Financier
D
Daniel Parera
Partner
F
Fatima Boubnad
Assistante de gestion
F
Florence De Coorebyter
Partner
F
Florence de Coorebyter
Associate
H
Hadrien Bouchez
Partner
H
Hadrien Bouchez 6a300b42
Partner
J
Jean Francois Rivassou
Partner
J
Jean-François Rivassou
Partner
L
Laura Achach
Partner
L
Louise-Marie Rakotoarison
Analyst
M
Maylis Deschamps
Associate
O
Ornella Gomis
Financial Controller
P
Peter Neubeck
Partner Germany
P
Philippe Peltier
Partner
P
Philippe Peltier 1a63102
Partner
R
R%c3%a9mi Droller B147671
Partner
R
Rémi Droller
Managing Partner
S
Samantha Ventura Zennou
Partner
S
Samantha Zennou
Associate
S
Sonny Guilhem
Senior Financial Controller
T
Thierry Laugel
Managing Partner
T
Thierry Laugel 414b981
Partner
